To further classify potential immune responses in the orthotopic lung cancer mouse model treated with combined therapy, the status of several immune cell phenotypes including mature DCs (CD11c+) in lymph nodes (LNs) and effector memory CD8+ T cells (TEms, CD44+ and CD62L−) in spleen were evaluated. This evidence concerns the gene ITGAX and lung carcinoma.